NovoPanthen (Ointment, Aerosol) Instructions for Use
ATC Code
D03AX03 (Dexpanthenol)
Active Substance
Dexpanthenol (Rec.INN registered by WHO)
Clinical-Pharmacological Group
A drug improving trophism and tissue regeneration, for external use
Pharmacotherapeutic Group
Drugs for the treatment of wounds and ulcers; drugs promoting normal scarring; other drugs promoting normal scarring
Pharmacological Action
A tissue regeneration stimulator, belongs to the B vitamins. Dexpanthenol is a precursor of pantothenic acid. In the body, it is converted into pantothenic acid, which is a constituent part of coenzyme A and participates in acetylation processes, carbohydrate and fat metabolism, and in the synthesis of acetylcholine, corticosteroids, and porphyrins; it stimulates the regeneration of the skin and mucous membranes, normalizes cellular metabolism, accelerates mitosis, and increases the strength of collagen fibers. It has a regenerating, metabolic, and weak anti-inflammatory effect.
Data obtained from animal experiments indicate an increase in fibroblast proliferation and the presence of a regenerating effect. When applied externally and locally, Dexpanthenol is able to compensate for the increased need of damaged skin or mucous membranes for pantothenic acid.
Pharmacokinetics
Dexpanthenol is quickly absorbed by the skin and converted into pantothenic acid.
It binds to blood plasma proteins (mainly to albumin and β-globulin).
Pantothenic acid is not metabolized in the body and is excreted unchanged.
Indications
Violation of the integrity of the skin: healing of burns (including sunburns), minor skin injuries (including abrasions, cuts, cracks); prevention and treatment of dry skin, including as a consequence of dermatitis of various origins; daily care of skin areas most exposed to external factors (face, hands); care of the mammary glands during lactation (cracks and redness of the nipples of the mammary gland); care for infants and babies (diaper rash, diaper dermatitis).
ICD codes
| ICD-10 code | Indication |
| L20 | Atopic dermatitis |
| L20.8 | Other atopic dermatitis (neurodermatitis, eczema) |
| L22 | Diaper dermatitis |
| L23 | Allergic contact dermatitis |
| L24 | Irritant contact dermatitis |
| L28.0 | Lichen simplex chronicus (circumscribed neurodermatitis) |
| L30.4 | Erythematous intertrigo |
| L30.9 | Dermatitis, unspecified |
| L55 | Sunburn |
| L56.2 | Photocontact dermatitis [berloque dermatitis] |
| O92.1 | Cracked nipple associated with childbirth |
| R23.4 | Changes in skin texture |
| T14.0 | Superficial injury of unspecified body region (including abrasion, bruise, contusion, hematoma, bite of nonvenomous insect) |
| T30 | Burns and corrosions of unspecified body region |
| ICD-11 code | Indication |
| 9A06.70 | Atopic eczema of the eyelids |
| EA80.0 | Infantile atopic eczema |
| EA80.1 | Childhood atopic eczema |
| EA80.2 | Adult atopic eczema |
| EA80.Z | Atopic eczema, unspecified |
| EA83.00 | Lichen simplex of vulva |
| EA83.01 | Lichen simplex of male genital organs |
| EA83.02 | Lichen simplex of perianal area |
| EA83.0Z | Lichen simplex of unspecified location |
| EA85.20 | Atopic hand eczema |
| EA85.2Z | Hand dermatitis, unspecified |
| EA85.3 | Foot dermatitis |
| EA89 | Generalized eczematous dermatitis of unspecified type |
| EA8Z | Dermatitis or eczema, unspecified |
| EE21 | Epidermal fragility |
| EH40.10 | Diaper dermatitis |
| EH92 | Dermatoses provoked by friction or mechanical impact |
| EH92.1 | Blister due to friction |
| EK00.Z | Allergic contact dermatitis, unspecified |
| EK02.20 | Intertriginous dermatitis due to friction, sweating or contact with body fluids |
| EK02.Z | Irritant contact dermatitis, unspecified |
| EK20 | Photoallergic reaction to fragrances or cosmetic products |
| JB46.1 | Cracked nipple associated with childbirth |
| KC30 | Fragile skin of prematurity |
| ME66.1 | Changes in skin texture |
| ND56.0 | Superficial injury of unspecified body region |
| NE11 | Burn of unspecified body region |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Apply a thin layer of the ointment or spray to the affected skin areas.
Gently rub in the preparation until fully absorbed.
For minor wounds, cuts, and abrasions, apply 2-3 times daily.
For sunburns and thermal burns, apply 3-4 times daily or as needed for symptomatic relief.
For the prevention and treatment of dry skin, apply 1-2 times daily to clean, dry skin.
For daily skin care of exposed areas like hands and face, apply once daily.
For cracked nipples during lactation, apply after each feeding; thoroughly remove any residue before the next feeding.
For diaper rash and diaper dermatitis in infants, apply with each diaper change to clean, dry skin.
When using the aerosol, hold the container upright and spray from a distance of approximately 10-15 cm.
The frequency of application depends on the severity of the condition and the indication.
Continue treatment until the skin condition is fully resolved.
If symptoms persist or worsen after 7-10 days, discontinue use and consult a physician.
Avoid contact with eyes and mucous membranes. Do not apply to heavily exuding or deeply infected wounds without medical supervision.
Adverse Reactions
In very rare cases, allergic reactions are possible.
Contraindications
Hypersensitivity to dexpanthenol.
Use in Pregnancy and Lactation
Can be used during pregnancy and breastfeeding.
Storage Conditions
Store at 15°C (59°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Ointment for external use 5%: jars or tubes 25 g, 30 g, 40 g, 50 g, or 100 g
Marketing Authorization Holder
Genel RD, LLC (Russia)
Manufactured By
Samaramedprom, OJSC (Russia)
Dosage Form
| NovoPanthen | Ointment for external use 5%: jars or tubes 25 g, 30 g, 40 g, 50 g, or 100 g |
Dosage Form, Packaging, and Composition
Ointment for external use from white with a yellowish tint to light yellow in color, homogeneous, with a characteristic odor.
| 100 g | |
| Dexpanthenol | 5 g |
Excipients: petrolatum – 13 g, liquid paraffin – 20 g, lanolin – 25 g, cetearyl alcohol [cetyl alcohol 60%, stearyl alcohol 40%] – 3 g, white beeswax – 3 g, methylparahydroxybenzoate – 0.07 g, propylparahydroxybenzoate – 0.03 g, purified water – 30.9 g.
25 g – dark glass jars (1) – cardboard packs.
30 g – dark glass jars (1) – cardboard packs.
40 g – dark glass jars (1) – cardboard packs.
50 g – dark glass jars (1) – cardboard packs.
100 g – dark glass jars (1) – cardboard packs.
25 g – polyethylene jars (1) – cardboard packs.
30 g – polyethylene jars (1) – cardboard packs.
40 g – polyethylene jars (1) – cardboard packs.
50 g – polyethylene jars (1) – cardboard packs.
100 g – polyethylene jars (1) – cardboard packs.
25 g – aluminum tubes (1) – cardboard packs.
30 g – aluminum tubes (1) – cardboard packs.
40 g – aluminum tubes (1) – cardboard packs.
50 g – aluminum tubes (1) – cardboard packs.
100 g – aluminum tubes (1) – cardboard packs.
Aerosol for external use 5%: aerosol cans 58 g 1 pc.
Marketing Authorization Holder
Genel RD, LLC (Russia)
Manufactured By
Samaramedprom, OJSC (Russia)
Dosage Form
| NovoPanthen | Aerosol for external use 5%: aerosol cans 58 g 1 pc. |
Dosage Form, Packaging, and Composition
Foam for external use: the preparation forms a white foam with a faint characteristic odor upon release from the can.
| 1 can | |
| Dexpanthenol | 2.5 g |
Excipients: cetearyl alcohol emulsifying type A (cetearyl alcohol 80%, sodium cetearyl sulfate 7%), macrogol glyceryl cocoate, propylene glycol, methylparahydroxybenzoate, potassium dihydrogen phosphate, sodium phosphate dodecahydrate, purified water, tetrafluoroethane (propellant 134a).
58 g – aluminum aerosol cans (1) – cardboard packs.
